Gapping up
In reaction to strong earnings/guidance:
- HAL +2.3%, LOGI +1.8%
Other news:
- ERF +4.6% (announced its 2020 exploration and development capital budget of $520 to $570 million and outlook through 2022)
- SERV +3.4% (will explore strategic alternatives for its ServiceMaster Brands business, including a potential sale of the segment, reaffirms FY 19 revs outlook of $2.07-2.085 bln)
- AXNX +3.2% (announces FDA approval of enhanced neurostimulator programmer)
- BYND +2.6% (Canadian regulators approve Impossible Foods plant based burgers in Canada)
- BBBY +2.3% (positive view in Barrons)
- UBER +1.6% (sold food delivery business in India to Zomato)
- WES +1.4% (raises quarterly distribution)
- HCM +1% (announces that Surufatinib Phase III SANET-p study has already achieved its primary endpoint in advanced pancreatic neuroendocrine tumors in China and will stop early)
Analyst comments:
- ARAY +6.1% (upgraded to Buy from Neutral at BTIG Research)
- AVYA +5.8% (upgraded to Buy from Neutral at Goldman)
- LB +2.8% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- FMS +2.6% (upgraded to Buy from Hold at Jefferies)
- DT +2.5% (initiated with an Outperform at BMO Capital Markets)